iiinova — where your digital self keeps evolving

AD Knowledge Portal @adknowledgeportal.bsky.social · 15/09/2026

Join us for the free annual workshop 10/22 on how to work with AD Knowledge Portal data. This hands-on virtual workshop will introduce Portal infrastructure and how to find data and metadata. If you’d like to participate, please indicate your interest: forms.gle/gZQzwhiVd2Cv...

forms.gle

AD Knowledge Portal Technical Workshop

This is the interest and registration form for the AD Knowledge Portal Technical Workshop, scheduled for Thursday, October 22 from 10:00am - 12:00pm PST (1 - 3pm EST). For questions, please contact zo...

000

AD Knowledge Portal @adknowledgeportal.bsky.social · 12/09/2026

The Portal has a new look! 🎉 Explore quick links to commonly searched studies, streamlined search, and new data - including lipidomics, metabolomics, proteomics, phosphoproteomics, and spatial transcriptomics. Check out the changes! adknowledgeportal.org

adknowledgeportal.org

AD Knowledge Portal

Discover and download Alzheimer's Disease data, analyses, and tools from the National Institute on Aging's Alzheimer's Disease Translational Research Program.

001

AD Knowledge Portal @adknowledgeportal.bsky.social · 15/07/2026

The results are in! Attendees at #AAIC26 voted throughout the conference on which research areas will drive the next major breakthrough in #Alzheimers research. Join us at #AAIC27 to see how the field changes! #endAlz @model-ad.bsky.social

010

AD Knowledge Portal @adknowledgeportal.bsky.social · 15/07/2026

@model-ad.bsky.social’s Claudia Rangel-Barajas presenting her work at #AAIC26. Visit poster 542 to learn how age and diet interact to drive brain remodeling in a novel late-onset #Alzheimers disease mouse model #AAIC2026

020

AD Knowledge Portal @adknowledgeportal.bsky.social · 15/07/2026

UCI’s Claire Butler presenting at #AAIC26 her work on the potential for reversing #Alzheimers pathology. Learn more about how her team uses @model-ad.bsky.social‘s mouse models today at poster 289!

010

AD Knowledge Portal @adknowledgeportal.bsky.social · 14/07/2026

If this informal conference poll at #AAIC26 is any indication, the next major breakthrough in #Alzheimers won’t come from a single approach. Instead, attendees voted for precision medicine and combination therapies; & enthusiasm for other pathways. Weigh in at booth 901E today!

000

AD Knowledge Portal @adknowledgeportal.bsky.social · 14/07/2026

📰 Updates from #AAIC26: The community continues to weigh in on the next major breakthroughs in #Alzheimers disease! Visit booth 901 in the @NIH Pavilion to share your thoughts and learn about the #OpenData and resources available to help accelerate your research and #endAlz!

000

AD Knowledge Portal @adknowledgeportal.bsky.social · 13/07/2026

Monday update from the community at #AAIC2026: optimism about precision medicine, inflammation, and mitochondrial function; plus an attendee-added category of diagnostic specificity! Stop by booth 901E in the NIH Pavilion to share what you're excited about (or skeptical of!) in #Alzheimers research!

010

AD Knowledge Portal @adknowledgeportal.bsky.social · 13/07/2026

Thanks to Douglas Nelson for stopping by booth 901E and sharing his perspective on the future of #Alzheimers research. Let us know what you think of the biggest areas in research at #AAIC2026 in London! #EndAlz #AAIC26

010

AD Knowledge Portal @adknowledgeportal.bsky.social · 13/07/2026

Stop by the NIH Pavilion at booth 901 to take a #London themed group photo! And, at 10:40 this morning, you can learn from @Sagebio's @emkcosta about the AD Knowledge Portal! #AAIC2026 #AAIC26 #endAlz @model-ad.bsky.social

071

AD Knowledge Portal @adknowledgeportal.bsky.social · 13/07/2026

If you’re at #AAIC2026 in London, stop by Booth 901 in the NIH Pavilion for brain pens, free data resources, and more! 🧠✨ #EndALZ @model-ad.bsky.social

030

AD Knowledge Portal @adknowledgeportal.bsky.social · 12/07/2026

Giedre Milinkeviciute engages attendees interested in her poster at #AAIC2026. Stop by booth 227 to learn more! #EndALZ @model-ad.bsky.social

020

AD Knowledge Portal @adknowledgeportal.bsky.social · 12/07/2026

What will drive the next major breakthrough in Alzheimer's disease? If you're in London for #AAIC2026, stop by the NIH Pavilion at booth 901 to share your thoughts on the research areas with the greatest potential to #EndAlz!

000

AD Knowledge Portal @adknowledgeportal.bsky.social · 22/06/2026

📣 We want to hear from you! Take our 10-minute community survey to help shape the future of the portal, workshops, webinars, challenges, and conference programs. Your feedback will directly guide how we support #alzheimers researchers like you. Complete the survey today: sageb.io/X2KgGJ #EndAlz

sageb.io

AD Knowledge Portal (ADKP) Survey

Dear ADKP Community Member We the AD Knowledge Portal Data Coordinating Center Team at Sage Bionetworks invite you to participate in a survey designed to gather feedback on the AD Knowledge Portal (...

000

AD Knowledge Portal @adknowledgeportal.bsky.social · 06/05/2026

🚀Just launched: Model AD Explorer! An interactive platform to discover & compare next-gen mouse models for #Alzheimers disease. Find better models, accelerate discovery, & strengthen the translational impact of your research! Learn more: news.adknowledgeportal.org/introducing-...

news.adknowledgeportal.org

Introducing the Model AD Explorer - Portal – AD Knowledge

A New Way to Explore Mouse Models of Alzheimer’s disease A new web-based tool is helping researchers navigate the growing landscape of next-generation mouse models for Alzheimer’s disease. Calle...

001

AD Knowledge Portal @adknowledgeportal.bsky.social · 02/04/2026

Crowdsourced insight from the #AlzheimersDisease research community: #ADPD2026 attendees see the amyloid and tau hypotheses as most promising for treatment, followed by mitochondrial dysfunction. What do you think we’re still missing? #endalz @model-ad.bsky.social

A poster board asking the AD research community "How likely is it that each of the following will help treat Alzheimer's disease?" With stickers placed to indicate votes, the amyloid and tau hypotheses appear to be the top choices.

010